Pieter C F Stokkers
Overview
Explore the profile of Pieter C F Stokkers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
2807
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hos C, Tebbens M, Bezema T, Bosch J, Kraneveld A, Spooren C, et al.
Nutrients
. 2024 Dec;
16(23).
PMID: 39683421
Background And Aims: To improve quality of life (QoL), patients with inflammatory bowel diseases (Crohn's disease and ulcerative colitis) often self-experiment with lifestyle changes such as dietary modifications. The nature...
2.
Sandys O, Stokkers P, Te Velde A
Dig Dis Sci
. 2024 Jul;
70(1):49-73.
PMID: 38963463
In inflammatory bowel diseases (IBD), the most promising therapies targeting cytokines or immune cell trafficking demonstrate around 40% efficacy. As IBD is a multifactorial inflammation of the intestinal tract, a...
3.
Bosch S, de Menezes R, Pees S, Wintjens D, Seinen M, Bouma G, et al.
Sensors (Basel)
. 2022 Dec;
22(23).
PMID: 36501947
Sensor drift is a well-known disadvantage of electronic nose (eNose) technology and may affect the accuracy of diagnostic algorithms. Correction for this phenomenon is not routinely performed. The aim of...
4.
Stevens T, Haasnoot M, DHaens G, Buskens C, de Groof E, Eshuis E, et al.
Lancet Gastroenterol Hepatol
. 2020 Jul;
5(10):900-907.
PMID: 32619413
Background: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed...
5.
Bennebroek Evertsz F, Sprangers M, de Vries L, Sanderman R, Stokkers P, Verdam M, et al.
Behav Cogn Psychother
. 2019 Aug;
48(1):91-102.
PMID: 31423955
Background: According to cognitive behavioural theory, cognitive factors (i.e. underlying general dysfunctional beliefs and (situation) specific illness beliefs) are theorized to lead to outcomes like anxiety and depression. In clinical...
6.
de Groof E, Stevens T, Eshuis E, Gardenbroek T, Bosmans J, van Dongen J, et al.
Gut
. 2019 Jun;
68(10):1774-1780.
PMID: 31233395
Objective: Evaluate the cost-effectiveness of laparoscopic ileocaecal resection compared with infliximab in patients with ileocaecal Crohn's disease failing conventional therapy. Design: A multicentre randomised controlled trial was performed in 29...
7.
Bennebroek Evertsz F, Sprangers M, Sitnikova K, Stokkers P, Ponsioen C, Bartelsman J, et al.
J Consult Clin Psychol
. 2017 Sep;
85(9):918-925.
PMID: 28857595
Objective: Inflammatory bowel disease (IBD) is characterized by a low level of quality of life (QoL) and a high prevalence of anxiety and depression, especially in patients with poor QoL....
8.
Gardenbroek T, Pinkney T, Sahami S, Morton D, Buskens C, Ponsioen C, et al.
BMC Surg
. 2016 Jan;
16:1.
PMID: 26729191
No abstract available.
9.
van Dijk R, Kremer A, Smit W, van den Elzen B, Gulik T, Gouma D, et al.
Liver Int
. 2014 Jun;
35(4):1478-88.
PMID: 24905729
Background & Aims: Hepatocellular secretory failure induced by drugs, toxins or transient biliary obstruction may sometimes persist for months after removal of the initiating factor and may then be fatal...
10.
Wolfkamp S, Verseyden C, Vogels E, Meisner S, Boonstra K, Peters C, et al.
World J Gastroenterol
. 2014 Mar;
20(10):2664-72.
PMID: 24627602
Aim: To investigate if the presence of relevant genetic polymorphisms has effect on the effectual clearance of bacteria by monocytes and granulocytes in patients with Crohn's disease (CD). Methods: In...